JK

Jitendra Kanaiyalal Shah

Active Director Director DIN 09515526
DIN 09515526 First appointment Apr 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Jitendra Kanaiyalal Shah

Data last updated:

Jitendra Kanaiyalal Shah is a Director at Biotical Pharmaceuticals Private Limited (since 2022). The company operates in Pharma. Biotical Pharmaceuticals Private Limited reported revenue of ₹31.2 Lakh (FY 2025).

DIN 09515526
Primary Designation Director
Industry Pharma
First Appointment 11 Apr 2022
Oldest Company Age 7 yrs
Largest company Biotical Pharmaceuticals Private Limited · ₹31.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Apr 20222019₹31.2 Lakh (FY 2025)Active

Board colleagues of Jitendra Kanaiyalal Shah

NameDINCompanyDesignation
Rujit Jitendra Shah08140260Biotical Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Biotical Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jitendra Kanaiyalal Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jitendra Kanaiyalal Shah

Jitendra Kanaiyalal Shah currently holds 1 directorship: Biotical Pharmaceuticals Private Limited (Director, since 11 Apr 2022, revenue ₹31.2 Lakh (FY 2025)).

Jitendra Kanaiyalal Shah was first appointed on 11 Apr 2022 as Director at Biotical Pharmaceuticals Private Limited.

The current boards of Jitendra Kanaiyalal Shah's companies include Rujit Jitendra Shah (Biotical Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available